Amrutanjan Health Care Limited shareholders approved a final dividend of ₹2.90 per equity share for the financial year ended March 31, 2026, during the company's 89th Annual General Meeting (AGM).

The meeting was held on September 23, 2026, at 10:30 am via Video Conferencing and Other Audio-Visual Means. A total of 120 shareholders participated in the virtual session, with 24 speakers addressing the board.

Resolutions passed

The following ordinary resolutions were put to vote and approved by the members:

Meeting proceedings

S. Sambhu Prasad, Chairman and Managing Director, chaired the meeting. He presented key business highlights, including distribution networks, shareholder returns, and strategic pillars for growth. The notice dated August 11, 2026, was taken as read with member permission.

The Chairman noted that the Auditors' Report contained no qualifications. P Sriram of M/s. SPNP & Associates served as the scrutinizer for the e-voting process facilitated by CDSL. Voting results will be declared on the company website within two working days of the meeting's conclusion.

The AGM concluded at 11:37 am with a vote of thanks to the Chair.

Amrutanjan Health Care Limited posted a Profit After Tax of ₹57.92 crore for FY26, up 13.93% from ₹50.83 crore in FY25, on gross sales of ₹559.56 crore against ₹509.68 crore a year earlier.

Revenue from operations grew 11.23% to ₹502.55 crore in FY26 from ₹451.82 crore in FY25. EBITDA rose to ₹66.83 crore from ₹58.20 crore, with EBITDA margin expanding to 13.30% from 12.88%. Profit Before Tax stood at ₹77.89 crore, up from ₹69.13 crore. The Board has recommended a final dividend of ₹2.90 per equity share for FY26, taking total dividend to ₹4.90 per share including two interim dividends of ₹1 each.

Key Financial Metrics

The table below captures FY26 performance against FY25 across headline indicators.

Segment Performance

The OTC Products segment reported net sales of ₹32,831.73 lakhs in FY26 against ₹29,002.99 lakhs in FY25, with segment results of ₹8,344.36 lakhs. The Women's Hygiene and Personal Care segment recorded net sales of ₹13,990.66 lakhs versus ₹12,396.25 lakhs, though segment results remained negative at ₹(272.16) lakhs, an improvement from ₹(391.05) lakhs in FY25. The Beverages segment posted net sales of ₹3,156.09 lakhs against ₹3,643.01 lakhs, with segment results of ₹(634.86) lakhs.

Brand and Category Growth

Pain management recorded 10% gross sales growth in FY26. Within the headache category, Head Roll-On sales grew 21%, with larger SKUs of 27.5 ml and 50 ml growing 17% and the 8 ml pack growing 4%. In the body ache category, Maha Strong grew 22% and Back Pain Roll-On grew 12%. The Relief congestion range recorded 9% gross sales growth, with Relief Inhaler up 16% and Relief Rubs up 15%.

Comfy, the Women's Hygiene brand, recorded 19% gross sales growth in FY26. The XL variant grew 44% and the 18-unit Value Pack grew 42%. The XL variant's contribution to overall Comfy sales rose from 31% in FY25 to 37% in FY26. The Women's Hygiene category achieved gross revenue of ₹151.31 crore in FY26, compared with ₹127.79 crore in FY25.

Revenue Contribution by Product Range

Digital and Export Channels

The E-commerce channel recorded revenue of ₹14.12 crore in FY26, registering growth of 48.8% over the previous year. The Quick Commerce channel recorded revenue of ₹7.55 crore, representing growth of 84.2% over the previous year. Export revenue reached ₹11.15 crore in FY26, up 36.1% over the previous year, with Africa accounting for 81% of total exports.

Manufacturing Investment

Amrutanjan commissioned a Greenfield Sanitary Napkin Manufacturing Facility at Seetharampur Village, Rangareddy District, Telangana. The ₹150 crore investment covers 10 acres with a 1.40 lakh sq. ft. built-up area and features two fully automated high-speed production lines from Japan, with a planned annual production capacity of 700 million sanitary napkins. The facility is expected to generate 200 direct and 150 indirect employment opportunities.

Distribution and Operational Highlights

The Company added 44,000 new chemist outlets during FY26 and plans to add 1,00,000 chemists by FY2027. Total distribution reach expanded to 1.12 million retail outlets across India. The network comprised 3,994 distributors and sub-distributors as of FY26.

CSR Spend

Total CSR spend in FY26 was ₹1,29,18,087.08, exceeding the mandatory obligation of ₹1,23,15,040.80. Initiatives spanned education, health and sanitation, animal welfare, and environmental sustainability across multiple states.

Five-Year Financial Trend